Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,inventory,accountsPayable,otherAssets,deferredLongTermAssetCharges,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,repurchaseOfStock,issuanceOfStock,dividendsPaid,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingPE,priceHint,exchange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchangeDataDelayedBy,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry
t0,PSG.DE,9741000.0,12000000,,,190000,,112000,1039000,14286000,195000,195000,12910000,-10000,,,,78000,16324000,16129000,2038000,-5000,,112000,112000,1766000.0,13437000.0,11507000.0,3006000.0,24944000.0,12000000.0,240000.0,-38613000.0,257000.0,38120000.0,8001000.0,13035000.0,38120000.0,753000.0,22365000.0,60000.0,11088000.0,3036000.0,9790000.0,,,2602000.0,-125000.0,-146000.0,-121000.0,-245000.0,1397000.0,1643000.0,142000.0,-940000.0,2950000.0,25000.0,-2978000.0,353000.0,,,,9330000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,24.3,1630574541,0.0,24.3,24.3,24.3,187,0.0,24.3 - 24.3,24.3,24.0,24.3,finmb_669391457,XETRA,PharmaSGP Holding SE,EUR,2314,449,9.9,0.6875,14.4 - 33.6,-9.299999,-0.2767857,14.4,33.6,27.30337,2,GER,0.89,0.965,23.18,1.1199989,0.04831747,21.040281,3.259718,0.15492749,290710624,25.181347,15,Europe/Berlin,CEST,7200000,False,False,0,PHARMASGP HOLDING SE O.N.,de_market,REGULAR,,,,33.6,14.4,23.18,21.04,2.31k,449,12M,,4M,66.46%,18.14%,,,,,,,,,,,,,,,,"Dec 31, 2020","Dec 31, 2020",16.40%,21.96%,44.30%,19.87%,64.88M,5.43,-4.20%,58.67M,14.73M,10.64M,0.89,-98.10%,8M,0.67,384k,3.34,1.72,0.96,15.46M,-75.69M,Value,82166,Healthcare,"PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in GrÃ¤felfing, Germany.",GrÃ¤felfing,89 85 89 639 150,Germany,http://pharmasgp.com,86400,Lochhamer Schlag 21,89 85 89 639 201,Drug Manufacturers—Specialty & Generic
t-1,PSG.DE,9807000.0,12000000,,,4502000,,3422000,-14849000,11677000,3407000,3407000,22991000,-28000,,,,1080000,13088000,9681000,1411000,1095000,,3422000,3422000,1587000.0,12173000.0,11394000.0,3747000.0,23567000.0,12000000.0,312000.0,10528000.0,298000.0,-11134000.0,6604000.0,11684000.0,-11134000.0,758000.0,21161000.0,60000.0,10751000.0,3494000.0,7708000.0,1000.0,,-3803000.0,-221000.0,-2000.0,-30000.0,56000.0,1344000.0,1596000.0,128000.0,-940000.0,1437000.0,92000.0,356000.0,-221000.0,-120000.0,,,9477000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,24.3,1630574541,0.0,24.3,24.3,24.3,187,0.0,24.3 - 24.3,24.3,24.0,24.3,finmb_669391457,XETRA,PharmaSGP Holding SE,EUR,2314,449,9.9,0.6875,14.4 - 33.6,-9.299999,-0.2767857,14.4,33.6,27.30337,2,GER,0.89,0.965,23.18,1.1199989,0.04831747,21.040281,3.259718,0.15492749,290710624,25.181347,15,Europe/Berlin,CEST,7200000,False,False,0,PHARMASGP HOLDING SE O.N.,de_market,REGULAR,,,,33.6,14.4,23.18,21.04,2.31k,449,12M,,4M,66.46%,18.14%,,,,,,,,,,,,,,,,"Dec 31, 2020","Dec 31, 2020",16.40%,21.96%,44.30%,19.87%,64.88M,5.43,-4.20%,58.67M,14.73M,10.64M,0.89,-98.10%,8M,0.67,384k,3.34,1.72,0.96,15.46M,-75.69M,Value,82166,Healthcare,"PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in GrÃ¤felfing, Germany.",GrÃ¤felfing,89 85 89 639 150,Germany,http://pharmasgp.com,86400,Lochhamer Schlag 21,89 85 89 639 201,Drug Manufacturers—Specialty & Generic
t-2,PSG.DE,6457000.0,12000000,,,5165000,,3869000,7939000,17185000,6334000,6334000,2802000,-49000,,,,1296000,18730000,12396000,1545000,-1169000,,3869000,3869000,1515000.0,16154000.0,7972000.0,5241000.0,24126000.0,12000000.0,242000.0,7106000.0,234000.0,-11134000.0,5260000.0,15671000.0,-11134000.0,794000.0,21493000.0,60000.0,13453000.0,2538000.0,10198000.0,264000.0,264000.0,6732000.0,-470000.0,-33000.0,-94916000.0,-48000.0,-88077000.0,7308000.0,110000.0,-940000.0,-2278000.0,-170000.0,-1077000.0,-470000.0,-120000.0,120000.0,-94833000.0,5822000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,24.3,1630574541,0.0,24.3,24.3,24.3,187,0.0,24.3 - 24.3,24.3,24.0,24.3,finmb_669391457,XETRA,PharmaSGP Holding SE,EUR,2314,449,9.9,0.6875,14.4 - 33.6,-9.299999,-0.2767857,14.4,33.6,27.30337,2,GER,0.89,0.965,23.18,1.1199989,0.04831747,21.040281,3.259718,0.15492749,290710624,25.181347,15,Europe/Berlin,CEST,7200000,False,False,0,PHARMASGP HOLDING SE O.N.,de_market,REGULAR,,,,33.6,14.4,23.18,21.04,2.31k,449,12M,,4M,66.46%,18.14%,,,,,,,,,,,,,,,,"Dec 31, 2020","Dec 31, 2020",16.40%,21.96%,44.30%,19.87%,64.88M,5.43,-4.20%,58.67M,14.73M,10.64M,0.89,-98.10%,8M,0.67,384k,3.34,1.72,0.96,15.46M,-75.69M,Value,82166,Healthcare,"PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in GrÃ¤felfing, Germany.",GrÃ¤felfing,89 85 89 639 150,Germany,http://pharmasgp.com,86400,Lochhamer Schlag 21,89 85 89 639 201,Drug Manufacturers—Specialty & Generic
t-3,PSG.DE,97502000.0,12000000,,,4292000,,3237000,9644000,15526000,4313000,4313000,1463000,-22000,,,,1055000,16738000,12425000,1212000,-21000,,3237000,3237000,1436000.0,10152000.0,98938000.0,6115000.0,109090000.0,98938000.0,188000.0,,241000.0,,93337000.0,9911000.0,,3000.0,107651000.0,,11819000.0,2307000.0,3793000.0,,,3366000.0,-82000.0,-66000.0,32000.0,-15000.0,4861000.0,4911000.0,106000.0,-940000.0,-692000.0,98000.0,-1091000.0,-82000.0,-120000.0,120000.0,-94833000.0,97740000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,24.3,1630574541,0.0,24.3,24.3,24.3,187,0.0,24.3 - 24.3,24.3,24.0,24.3,finmb_669391457,XETRA,PharmaSGP Holding SE,EUR,2314,449,9.9,0.6875,14.4 - 33.6,-9.299999,-0.2767857,14.4,33.6,27.30337,2,GER,0.89,0.965,23.18,1.1199989,0.04831747,21.040281,3.259718,0.15492749,290710624,25.181347,15,Europe/Berlin,CEST,7200000,False,False,0,PHARMASGP HOLDING SE O.N.,de_market,REGULAR,,,,33.6,14.4,23.18,21.04,2.31k,449,12M,,4M,66.46%,18.14%,,,,,,,,,,,,,,,,"Dec 31, 2020","Dec 31, 2020",16.40%,21.96%,44.30%,19.87%,64.88M,5.43,-4.20%,58.67M,14.73M,10.64M,0.89,-98.10%,8M,0.67,384k,3.34,1.72,0.96,15.46M,-75.69M,Value,82166,Healthcare,"PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in GrÃ¤felfing, Germany.",GrÃ¤felfing,89 85 89 639 150,Germany,http://pharmasgp.com,86400,Lochhamer Schlag 21,89 85 89 639 201,Drug Manufacturers—Specialty & Generic
